Dietary lycopene has a protective effect on cardiovascular disease in New Zealand male rabbits

Journal of Biological Sciences

Volumn 8, Issue 2, 2008, Pages 268-277

  Verghese, Martha ^a   Richardson, J E ^b   Boateng, J ^a   Shackelford, L A ^a   Howard, C ^a   Walker, L T ^a   Chawan, C B ^b  

^a ALABAMA A AND M UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

ACAT; Aorta plaques; Atherosclerotic cardiovascular disease (ASCVD); HMG CoA; Lycopene; Serum lipids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; HEART PROTECTION; HYPERCHOLESTEROLEMIA; LIVER; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ORYCTOLAGUS CUNICULUS;

EID: 52349114345     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2008.268.277     Document Type: Article

References (86)

1. Agarwal, S. and A.V. Rao, 1998. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study. Lipids, 33 (10): 981-984.
2. Agarwal, S. and A.V. Rao, 2000. Tomato lycopene and its role in human health and chronic diseases. CMAJ., 163 (6): 739-744.
3. Ahuja, K.D., D. Kunde and M.J. Ball, 2003a. Effects of olive oil and tomato lycopene combination on heart disease risk factors. Asia Pac. J. Clin. Nutr., 12 Suppl., S21.
4. Ahuja, K.D., E.L. Ashton and M.J. Ball, 2003b. Effects of a high monounsaturated fat, tomato-rich diet on serum levels of lycopene. Eur. J. Clin. Nutr., 57 (7): 832-841.
5. Ahuja, K.D., J.K. Pittaway and M.J. Ball, 2006. Effects of olive oil and tomato lycopene combination on serum lycopene, lipid profile and lipid oxidation. Nutrition, 22 (3): 259-265.
6. Allain, C.C., L.S. Poon, C.S. Chan, W. Richmond and P.C. Fu, 1974. Enzymatic determination of total serum cholesterol. Clin. Chem., 20 (4): 470-475.
7. American Heart Association, 2003. Heart disease and stroke statistics update. Dallas, TX: American Heart Association.
8. Amin, D., S.K. Gustafson, J.M. Weinacht, S.A. Cornell, K. Neuenschwander and B. Kosmider, 1993. RG 12561 (dalvastatin): A novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent. Pharmacology, 46 (1): 13-22.
9. Anderson, J.W., 1987. Dietary fiber, lipids and atherosclerosis. Am. J. Cardiol., 60 (12): 17G-22G.
10. Appel, L.J., T.J. Moore, E. Obarzanek, W.M. Vollmer, L.P. Svetkey and F.M. Sacks, 1997. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N. Engl. J. Med., 336 (16): 1117-1124.
11. Arab, L. and S. Steck, 2000. Lycopene and cardiovascular disease. Am. J. Clin. Nutr., 71 (6 Suppl): 1691S-5S.
12. Aust, O., N. Ale-Agha, L. Zhang, H. Wollersen, H. Sies and W. Stahl, 2003. Lycopene oxidation product enhances gap junctional communication. Food Chem. Toxicol., 41 (10): 1399-1407.
13. Aviram, M., M. Rosenblat, D. Gaitini, S. Nitecki, A. Hoffman and L. Dornfeld, 2004. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr., 23 (3): 423-433.
14. Bandyopadhyay, S.K., S.C. Pakrashi and A. Pakrashi, 2000. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J. Ethnopharmacol., 70 (2): 171-176.
15. Batta, A.K., G. Salen, P. Batta, G.S. Tint, D.S. Alberts and D.L. Earnest, 2002. Simultaneous quantitation of fatty acids, sterols and bile acids in human stool by capillary gas-liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 775(2): 153-161.
16. Blum, A., M. Monir, I. Wirsansky and S. Ben-Arzi, 21)()5. The beneficial effects of tomatoes. Eur. J. Int. Med. 16 (6): 402-404.
17. Bucolo, G. and H. David, 1973. Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem., 19 (5): 476-482.
18. Cardinault, N., J.H. Abalain B. Sairafi, C. Coudray, P. Grolier and M. Rambeau, 2005. Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clin. Chim. Acta, 352 (1): 34-42.
19. Carmena-Ramon, R., J.T. Real, J.F. Ascaso, J.M. Ordovas and R. Carmena, 2()()(). Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia. Nutr. Metab. Cardiovasc. Dis., 10 (1): 7-13.
20. Chan, P.T., W.P. Fong, Y.L. Cheung, Y. Huang, W.K. Ho and Z.Y. Chen, 1999. Jasmine green tea epicatechins are hypolipidemic in hamsters ( Mesocricetus auratus) fed a high fat diet. J. Nutr. 129 (6): 1094-1101.
21. Cheung, P.C., 1998. Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets. J. Nutr. 128 (9): 1512-1516.
22. Czubayko, F., B. Beumers, S. Lammsfuss, D. Lutjohann and K.A. Von Bergmann, 1991. Simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J. Lipid Res., 32 (11): 1861-1867.
23. Dugas, T.R., D.W. Morel and E.H. Harrison 1999. Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radic. Biol. Med. 26 (9-10): 1238-1244.
24. Erickson, S.K., M.A. Shrewsbury, C. Brooks and D.J. Meyer, 198(). Rat liver acyl-coenzyme A: Cholesterol acyltransferase: Its regulation in vivo and some of its properties in vitro. J. Lipid Res. 21 (7): 930-941.
25. Fielding, J.M., K.G. Rowley, P. Cooper and K. O' Dea, 2005. Increases in plasma lycopene concentration after consumption of tomatoes cooked with olive oil. Asia Pac. J. Clin. Nutr., 14 (2): 131-136.
26. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (6): 499-502.
27. Gillies, P.J., K.A. Rathgeb, M.A. Perri and C.S. Robinson, 1986. Regulation of acyl-CoA: Cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: Role of a cholesterol substrate pool. Exp. Mol. Pathol., 44 (3): 329-339.
28. Giovannucci, E., 2002. A review of epidemiologic studies of tomatoes, lycopene and prostate cancer. Exp. Biol. Med., 222 (10): 852-859.
29. Giugliano, D., 2000. Dietary antioxidants for cardiovascular prevention. Nutr. Metab. Cardiovasc. Dis., 10: 38-44.
30. Grundy, S.M., T. Bazzarre, J. Cleeman, R.B. Sr. D'Agostino, M. Hill and N. Houston-Miller, 2000 Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Medical office assessment: Writing Group I. Circulation, 101 (1): E3-E11.
31. Halliwell, B., 1994. Free radicals, antioxidants and human disease: Curiosity, cause, or consequence? Lancet, 344 (8924): 721-724.
32. Helgerud, P., K. Saarem and K.R. Norum, 1981. Acyl-CoA: Cholesterol acyltransferase in human small intestine: Its activity and some properties of the enzymic reaction. J. Lipid Res., 22 (2): 221-222.
33. Hertog, M.G., E.J. Feskens and D. Kromhout, 1997. Antioxidant flavonols and coronary heart disease risk. Lancet, 349 (9053): 699.
34. Hulcher, F.H. and W.H. Oleson, 1923. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J. Lipid Res., 14 (6): 625-31.
35. Iannelli, P., V. Zarrilli, E. Varricchio, D. Tramontano and F.P. Mancini, 2002. The dietary antioxidant resveratrol affects redox changes of PPARα activity. Nutr. Met. Cardiovas Dis., 12(4): 242-256.
36. Ikeda, T., Y. Shibuya, U. Senba, H. Sugiuchi, S. ArakiN and Y. Uji, 1991. Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays. J. Clin. Lab. Anal., 5 (2): 90-95.
37. Joshipura, K.J., A. Ascherio, J.E. Manson, M.J. Stampfer, E.B. Rimm and F.E. Speizer, 1999. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA., 282 (13): 1233-1239.
38. Kaliora, A.C., G.V. Dedoussis and H. Schmidt, 2005. Dietary antioxidants in preventing atherogenesis. Atherosclerosis, 187: 1-12.
39. Klipstein-Grobusch, K., L.J. Launer, J.M. Geleijnse, H. Boeing, A. Hofman and J.C. Witteman, 2000 Serum carotenoids and atherosclerosis. The rotterdam study. Atherosclerosis, 148 (1): 49-56.
40. Kohlmeier, L., J.D. Kark, E. Gomez-Gracia, B.C. Martin, S.E. Steck and A.F. Kardinaal, 1997. Lycopene and myocardial infarction risk in the EURAMIC Study. Am. J. Epidemiol., 146: 618-626.
41. Krinsky, N.I., J.T. Landrum and R.A. Bone, 2003. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr., 23: 171-201.
42. Krinsky, N.I. and E. J. Johnson, 2005. Carotenoid actions and their relation to health and disease. Mol. Aspects Med., 26 (6): 459-516.
43. Lee, A., D.I. Thurnham and M. Chopra, 2000 Consumption of tomato products with olive oil but not sunflower oil increases the antioxidant activity of plasma. Free Radic. Biol. Med., 29 (10): 1051-1055.
44. Liao, W. and G. Ning, 2006. Knockdown of apolipoprotein B, an atherogenic apolipoprotein, in HepG2 cells by lentivirus-mediated siRNA. Biochem. Biophys. Res. Commun., 344 (2): 428-483.
45. Lind, L., 2006. Vasodilation in resistance arteries is related to the apolipoprotein B/A1 ratio in the elderly. The prospective investigation of the vasculature in uppsala seniors (PIVUS) study. Atherosolerosis, 190 (2): 378-384.
46. Ling, W.H., Q.X. Cheng, J. Ma and T. Wang, 2001. Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. J. Nutr., 131 (5): 1421-1426.
47. Mazza, G., C.D. Kay, T. Cottrell and B.J. Holub, 2002. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J. Agric. Food Chem., 50 (26): 7731-7932.
48. Miller, E.R., L.J. Appel, D.A. Levander and D.M. Levine, 1997. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J. Cardiovasc. Risk., 4 (1): 19-24.
49. Muscat, J.E. and M. Huncharek, 1996. Dietary intake and the risk of malignant mesothelioma. Br. J. Cancer. 23 (9): 1122-1125.
50. Nahum, A., K. Hirsch, M. Danilenko, C.K. Watts, O.W. Prall and J. Levy, 2001. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27 (Kip1) in the cyclin E-cdk2 complexes. Oncogene, 20 (26): 3428-3436.
51. Ng, D.S., P.W. O'Connor, C.B. Mortimer, L.A. Leiter, P.W. Connelly and R.A. Hegele, 1996. Case report: Retinopathy and neuropathy associated with complete apolipoprotein A-I deficiency. Am. J. Med. Sci., 312: 30-33.
52. Nguyen, M.L. and S.J. Schwartz, 1998. Lycopene stability during food processing. Proc. Soc. Exp. Biol. Med. 218 (2): 101-105.
53. Nguyen L.B., S. Shefer, G. Salea G.S. Tint, F. Ruiz and J. Bullock, 2001. Mechanisms for cholesterol homeostasis in rat jejunal mucosa: Effects of cholesterol, sitosterol and lovastatin. J. Lipid Res., 42 (2): 195-200.
54. Nyyssonen K., E. Porkkala-Sarataho, J. Kaikkonen and J.T. Salonen 1992. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis, 130 (1-2): 223-233.
55. Omoni, A.D. and R.E. Aluko, 2005. The anti-carcinogenic and anti-atherogenic effects of lycopene: A review. Trends. Food Sci. Technol., 16 (8): 344-350.
56. Paiva, S.A. and R.M. Russell, 1999. Beta-carotene and other carotenoids as antioxidants. J. Am. Coll. Nutr., 18 (5): 426-433.
57. Pastori, M., H. Pfander, D. Boscoboinik and A. Azzi, 1998. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem. Biophys. Res. Commun., 250 (3): 582-585.
58. Prasad, K. and J. Kalra, 1993. Oxygen free radicals and hypercholesterolemic atherosolerosis: Effect of vitamin E. Am. Heart J., 125 (4): 958-973.
59. Prasad, K., 1999. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation, 99 (10): 1355-1362.
60. Rao, A.V. and S. Agarwal, 2000. Role of antioxidant lycopene in cancer and heart disease. J. Am. Coll. Nutr., 19 (5): 563-569.
61. Rao, A.V., 2002. Lycopene, tomatoes and the prevention of coronary heart disease. Exp. Biol. Med. 222 (10): 908-913.
62. Rice-Evans, C.A., N.J. Miller and G. Paganga, 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 20 (2): 933-956.
63. Robertson, R.M., 20001. Women and cardiovascular disease: The risks of misperception and the need for action. Circulation, 103 (19): 2318-2321).
64. Sesso, H.D., S. Liu, J.M. Gaziano and J.E. Buring, 2()(13. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J. Nutr., 133 (2): 2336-2341.
65. Sesso, H.D., J.E. Buring, E.P. Norkus and J.M. Gaziano, 2005. Plasma lycopene, other carotenoids and retinol and the risk of cardiovascular disease in men. Am. J. Clin. Nutr., 81 (5): 990-997.
66. Shapiro, D.J., J.L. Nordstrom, J.J. Mitschelen, V.W. Rodwell and R.T. Schimke, 1974. Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim. Biophys. Acta, 370 (2): 369-377.
67. Sies, H. and W. Stahl, 1998. Lycopene: Antioxidant and biological effects and its bioavailability in the human. Proc. Soc. Exp. Biol. Med., 218 (2): 121-124.
68. Smith, S.C. Jr., R. Jackson, T.A. Pearson, V. Fuster, S. Yusuf and O. Faergeman, 2004. Principles for national and regional guidelines on cardiovascular disease prevention: A scientific statement from the World Heart and Stroke Forum. Circulation, 109 (25): 3112-3121.
69. Stahl, W. and H. Sies, 1992. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans J. Nutr., 122 (11): 2161-2166.
70. Stahl, W. and H. Sies, 2005. Bioactivity and protective effects of natural carotenoids. Biochim. Biophys. Acta, 1740 (2): 101-107.
71. SAS, 2005. StatView® software Copyright © 2005. SAS Institute Inc., SAS Campus Drive, Cary, North Carolina 27513, USA.
72. Stein, O. and Y. Stein, 1999. Atheroprotective mechanisms of HDL. Atherosclerosis, 144 (2): 285-301.
73. Stock, A., H. Sies and W. Stahl, 1998. Enhancement of gap junctional communication and connexin43 expression by thyroid hormones. Biochem. Pharmacol., 55 (4): 475-479.
74. Street, D.A., G.W. Comstock, R.M. Salkeld, W. Schuep and M.J. Klag, 1994. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation, 90 (3): 1154-1161.
75. Sun, Y. and J. Chen, 2004. Intestinal electric stimulation decreases fat absorption in rats: Therapeutic potertial for obesity. Obes. Res., 12 (8): 1235-1242.
76. Thom, T., N. Haase, W. Rosamond, V.J. Howard, J. Rumsfeld and T. Manolio, 2006. American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2006 update: A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation, 113 (6): E85-151.
77. Thurman, D.I., 1994. Carotenoids: Function and fallacies. Proc. Nutr. Soc., 53: 77-87.
78. Tribble, L.D. Krauss and M. Ronald, 2001. Present Knowledge in Nutrition. 8th Edn. International Life Sciences Institute, pp: 543-551.
79. Wahlqvist, M.L., N. Wattanapenpaiboon, F.A. Macrae, J.R. Lambert, R. MacLennan and B.H. Hsu-Hage, 1994. Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of beta-carotene supplementation. Australian polyp prevention project Investigators. Am. J. Clin. Nutr., 60 (6): 936-943.
80. Walldius, G., I. Jungner, I. Holme, A.H. Aastveit, W. Kolar and E. Steiner, 2001. High apolipoprotein B, low apolipoprotein A-I and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Lancet, 358 (9298): 2026-2033.
81. Walldius, G., I. Jungner, A.H. Aastveit, I. Holme, C.D. Furberg and A.D. Sniderman, 2004. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin. Chem. Lab. Med., 42 (12): 1355-1363.
82. Willet, W., 1994. Coffee and coronary heart disease. A new problem with old brew? Ann. Epidemiol., 4 (6): 497-498.
83. Yanni, A.E., H.A. Yatzidis, N.G. Kavantzas, E.V. Agapitos, D.N. Perrea and P.E. Karayannacos, 2003. Dietary L-aspartate and L-glutamate inhibit fatty streak initiation in cholesterol-fed rabbit. Nutr. Metab. Cardiovasc. Dis., 13 (2): 80-86.
84. Yusuf, S., S. Hawken, S. Ounpuu, T. Dans, A. Avezum and F. Lanas, 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet, 364 (9438): 937-952.
85. Zhang, L. X., R.V. Cooney and J.S. Bertram, 1992. Carotenoids up-regulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res., 52 (20): 5707-5712.
86. Zhang, H., A. Sun, Y. Shen, J. Jia, S. Wang, K. Wang and J. Ge, 2004. Artery interposed to vein did not develop atherosclerosis and underwent atrophic remodeling in cholesterol-fed rabbits. Atherosclerosis, 177 (1): 37-41.